# Clario

> Clario, a part of Thermo Fisher Scientific, combines science\-informed endpoint technology, global scale, and expert services to generate reliable clinical evidence for every trial phase\.

Generated by Yoast SEO v28.7, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [About](https://clario.com/about/)
- [Contact](https://clario.com/contact/)
- [Cookie policy](https://clario.com/about/legal-and-privacy/cookie-policy/)
- [Clario Privacy Notice](https://clario.com/about/legal-and-privacy/privacy-policy/)
- [Case Studies](https://clario.com/resources/case-studies/)
- [Blog Articles](https://clario.com/resources/articles/)

## Case Studies
- [High\-quality compliant eCOA data captured across group of oncology studies](https://clario.com/resources/case-studies/high-quality-compliant-ecoa-data-captured-across-group-of-oncology-studies/)
- [Clario simplifies complex eCOA and imaging GI study with single\-vendor solution](https://clario.com/resources/case-studies/clario-simplifies-complex-ecoa-and-imaging-gi-study-with-single-vendor-solution/)
- [Phase 4 study achieves greater patient engagement \& improved data quality using electronic data capture](https://clario.com/resources/case-studies/phase-4-study-achieves-greater-patient-engagement-improved-data-quality-using-electronic-data-capture/)
- [Simple effectiveness study deploys electronic data capture solution despite tight timelines](https://clario.com/resources/case-studies/simple-effectiveness-study-deploys-electronic-data-capture-solution-despite-tight-timelines/)
- [De‑risking early phase oncology with expert cardiac safety](https://clario.com/resources/case-studies/clario-helps-establish-the-cardiac-safety-profile-of-a-novel-oncologic-in-early-phase/)

## Events
- [Lessons Learned in Neuroscience Drug Development: How Biomarker\-based, Evidence\-driven Decisions Enable Successful Outcomes](https://clario.com/resources/events/lessons-learned-in-neuroscience-drug-development-how-biomarker-based-evidence-driven-decisions-enable-successful-outcomes/)
- [MSToronto 2026 10th Joint ACTRIMS/ECTRIMS Meeting](https://clario.com/resources/events/mstoronto-2026-10th-joint-actrims-ectrims-meeting/)
- [18th Annual Outsourcing in Clinical Trials New England 2026](https://clario.com/resources/events/18th-annual-outsourcing-in-clinical-trials-new-england-2026/)
- [ESMO Congress 2026](https://clario.com/resources/events/esmo-congress-2026/)
- [2026 KoNECT\-MOHW International Conference](https://clario.com/resources/events/2026-konect-mohw-international-conference/)

## Newsroom Articles
- [Biological Psychiatry Study Shows Speech\-Latency Vocal Biomarker Can Strengthen Drug–Placebo Separation in Schizophrenia Trials ](https://clario.com/about/newsroom/biological-psychiatry-study-shows-speech-latency-vocal-biomarker-can-strengthen-drug-placebo-separation-in-schizophrenia-trials/)
- [Clario leads the way in responsible artificial intelligence with ISO 42001 certification, audited by Schellman](https://clario.com/about/newsroom/clario-leads-the-way-in-responsible-artificial-intelligence-with-iso-42001-certification-audited-by-schellman/)
- [Thermo Fisher Scientific to Acquire Clario, Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights](https://clario.com/about/newsroom/thermo-fisher-scientific-to-acquire-clario-enabling-pharma-and-biotech-customers-to-accelerate-innovation-with-deeper-clinical-insights/)
- [Clario and the University of Oxford’s NeuroMetrology Lab Advance Parkinson’s Disease Research with the Opal® Wearable Sensor System](https://clario.com/about/newsroom/clario-and-the-university-of-oxfords-neurometrology-lab-advance-parkinsons-disease-research-with-the-opal-wearable-sensor-system/)
- [Clario expands oncology trial support through collaboration with Radialogica to enhance radiation therapy quality control ](https://clario.com/about/newsroom/clario-expands-oncology-trial-support-through-collaboration-with-radialogica-to-enhance-radiation-therapy-quality-control/)

## Therapeutic Areas
- [Psychiatric Disorders](https://clario.com/therapeutic-areas/neuroscience/psychiatric-disorders/)
- [Oncology Clinical Trials](https://clario.com/therapeutic-areas/oncology/)
- [Multiple Sclerosis](https://clario.com/therapeutic-areas/neuroscience/multiple-sclerosis/)
- [Infectious Diseases](https://clario.com/therapeutic-areas/infectious-diseases/): Manage global infectious disease and vaccine trial research with greater ease and efficiency\.
- [Ophthalmology](https://clario.com/therapeutic-areas/ophthalmology/): Advance ophthalmic therapeutic from study start\-up to regulatory submission with proven site support, project management, and medical expertise\.

## Solutions
- [Clario Site Experience](https://clario.com/solutions/site-experience/)
- [Respiratory Solutions](https://clario.com/solutions/respiratory/): Clario generates high\-quality lung function test data through a combination of industry\-leading devices, respiratory expertise, site performance reviews to optimize selection, site data reviews, as well as software customization and integrated devices that exceed ATS/ERS guidelines\.
- [Fractional Exhaled Nitric Oxide \(FeNO\)](https://clario.com/solutions/respiratory/fractional-exhaled-nitric-oxide-feno/): Collect consistent, objective airway inflammation data across global respiratory trials\.
- [Medical Imaging](https://clario.com/solutions/medical-imaging/): Clario is the world leader in centralized medical imaging services for clinical trials\. Our SMART technology suite processes medical images in one secure and integrated system, from electronic image transfer to independent analysis and transfer\.
- [Medical imaging science team](https://clario.com/solutions/medical-imaging/medical-imaging-science-team/): The Clario team includes medical imaging experts and globally recognized key opinion leaders \(KOLs\) representing multiple disciplines\.

## Landing Page
- [Reduce variability and strengthen confidence in psychiatric trial outcomes](https://clario.com/reduce-variability-and-strengthen-confidence-in-psychiatric-trial-outcomes/)
- [In psychiatric trials, execution can make or break the readout](https://clario.com/in-psychiatric-trials-execution-can-make-or-break-the-readout/)
- [Accelerate Alzheimer's trial decisions with integrated, proven endpoint strategies](https://clario.com/accelerate-alzheimers-trial-decisions-with-integrated-proven-endpoint-strategies/)
- [Demonstrating efficacy and safety in Alzheimer's trials is complex \- we can help](https://clario.com/demonstrating-efficacy-and-safety-in-alzheimers-trials-is-complex/)
- [Meet your E14 regulatory requirements early with EPQT](https://clario.com/meet-your-e14-regulatory-requirements-early-with-epqt/)

## External Publications
- [Spirometry services in England post\-pandemic and the potential role of AI support software: a qualitative study of challenges and opportunities](https://clario.com/resources/external-publications/spirometry-services-in-england-post-pandemic-and-the-potential-role-of-ai-support-software-a-qualitative-study-of-challenges-and-opportunities/)
- [Artificial intelligence outperforms pulmonologists in the interpretation of pulmonary function tests](https://clario.com/resources/external-publications/artificial-intelligence-outperforms-pulmonologists-in-the-interpretation-of-pulmonary-function-tests/)
- [Artificial Intelligence Assists in Quality Assessment of Spirometry in Clinical Trials](https://clario.com/resources/external-publications/artificial-intelligence-assists-in-quality-assessment-of-spirometry-in-clinical-trials/)
- [Comparing performance of primary care clinicians in the interpretation of SPIROmetry with or without Artificial Intelligence Decision support software\(SPIRO\-AID\): a protocol for a randomized controlled trial](https://clario.com/resources/external-publications/comparing-performance-of-primary-care-clinicians-in-the-interpretation-of-spirometry-with-or-without-artificial-intelligence-decision-support-softwarespiro-aid-a-protocol-for-a-randomized-controlle/)
- [Deep\-learning algorithm helps to standardize ATS/ERS spirometric acceptability and usability criteria](https://clario.com/resources/external-publications/deep-learning-algorithm-helps-to-standardize-ats-ers-spirometric-acceptability-and-usability-criteria/)

## Articles
- [What is eCOA?](https://clario.com/resources/articles/what-is-ecoa-and-how-does-it-improve-clinical-trial-data-quality/)
- [Nonclinical Concentration\-QTc Modeling: Strengthening Cardiac Safety Assessment Earlier in Drug Development ](https://clario.com/resources/articles/nonclinical-c-qtc-modeling-cardiac-safety-assessment/)
- [A guide to respiratory endpoints in clinical trials](https://clario.com/resources/articles/a-guide-to-respiratory-endpoints-in-clinical-trials/)
- [Improving data quality in respiratory clinical trials](https://clario.com/resources/articles/improving-data-quality-in-respiratory-clinical-trials/)
- [Immunizations: Protecting the world from the ravages of disease](https://clario.com/resources/articles/immunizations-protecting-the-world-from-the-ravages-of-disease/)

## Webinars
- [Optimize Obesity Development: Endpoint Strategies for Early\-phase Innovation to Late\-phase Differentiation Webinar Replay](https://clario.com/resources/webinars/optimize-obesity-development-endpoint-strategies-for-early-phase-innovation-to-late-phase-differentiation-webinar-replay/)
- [Advancing MS Clinical Trials: Integrating Medical Imaging, Precision Motion Analysis, and eCOA Data for Enhanced Outcomes Webinar replay](https://clario.com/resources/webinars/advancing-ms-clinical-trials-integrating-medical-imaging-precision-motion-analysis-and-ecoa-data-for-enhanced-outcomes-webinar-replay/)
- [Advancing Alzheimer’s Clinical Trial Endpoints: Imaging Biomarkers, COA Challenges, Movement Measures, and CV Risk Webinar Replay](https://clario.com/resources/webinars/advancing-alzheimers-clinical-trial-endpoints-imaging-biomarkers-coa-challenges-movement-measures-and-cv-risk-webinar-replay/)
- [Risk\-Based Monitoring in Clinical Trials: Improve Oversight Through Intelligent Review of Digital Endpoint Data Webinar Replay](https://clario.com/resources/webinars/risk-based-monitoring-in-clinical-trials-improve-oversight-through-intelligent-review-of-digital-endpoint-data-webinar-replay/)
- [New Options for Avoiding a Dedicated TQT Study – The Impact of the New ICH E14/S7B Revisions Webinar Replay](https://clario.com/resources/webinars/new-options-for-avoiding-a-dedicated-tqt-study-the-impact-of-the-new-ich-e14-s7b-revisions-on-demand-webinar/)

## Downloads
- [AI\-enabled risk based monitoring – Cardiac Safety](https://clario.com/resources/downloads/ai-enabled-risk-based-monitoring-cardiac-safety/)
- [Top 5 questions biotech companies should ask to enable study success](https://clario.com/resources/downloads/top-5-questions-biotech-companies-should-ask-to-enable-study-success/)
- [Using eCOA for the first time](https://clario.com/resources/downloads/using-ecoa-for-the-first-time/)
- [AI\-enabled risk\-based monitoring \- Respiratory](https://clario.com/resources/downloads/ai-enabled-risk-based-monitoring-respiratory/)
- [Optimizing continuous ECG monitoring in clinical trials](https://clario.com/resources/downloads/optimizing-continuous-ecg-monitoring-in-clinical-trials/)

## Schema Tags
- [Phase III chronic weight management](https://clario.com/schema_tags/phase-iii-chronic-weight-management/)
- [BYOD approach](https://clario.com/schema_tags/byod-approach/)
- [Electronic data capture solutions](https://clario.com/schema_tags/electronic-data-capture-solutions/)
- [Collaborative data management](https://clario.com/schema_tags/collaborative-data-management/)
- [Single\-vendor solution with eCOA and imaging](https://clario.com/schema_tags/single-vendor-solution-with-ecoa-and-imaging/)

## Optional
- [Sitemap index](https://clario.com/sitemap_index.xml)